Insulin Mechanisms of Diabetes-Evoked Enhancement of Nicotine Reward
Role: Co-Investigator; Agency: NIDA; Type: R15 (DA040130); Total Costs: $300,000; Period: 9/1/15-8/30/18; Goal: To examine the neurochemical mechanisms by which insulin promotes the rewarding effects of nicotine.
Sex Differences in the Mechanisms that Promote Nicotine Reward and Withdrawal
Role: Primary Investigator; Agency: NIDA; Type: R01 (2DA021274); Total Costs: $2,000,000; Period: 5/1/14-4/30/19; Goal: To examine sex differences in the neurochemical mechanisms that promote the rewarding effects of nicotine and the aversive effects of withdrawal.
Research Excellence for Undergraduates (REU) Summer Mentoring And Research Training: Methods In Neuroscience of Drug-Abuse (SMART MIND).
Role: Primary Investigator; Agency: NIH/NIDA; Type: R25 (DA033613); Total costs: $534,879; Period: 5/1/12–4/31/16; Goal: To enrich the science education and research training of undergraduate students and high school teacher-student teams with a specific focus on the neuroscience of drug-addiction.
Diversity Institution Drug Abuse Research Program: Vulnerability Issues in Drug Abuse (VIDA)
Role: Collaborating Investigator on primary project entitled, Stress-induced increases in vulnerability to substance abuse and addiction; Agency: NIH/NIDA; Type: R24 (DA029989); Total costs: $1,712,042 ($168,087 for project); Period: 3/4/11–3/3/16; Goal: To train minority scientists in multidisciplinary approaches to study of drug abuse on the U.S./Mexico border. It is expected that vulnerability in this population will be highly influenced by stress, which may be worsened or alleviated by factors such as age and/or sex, which are the focus of our sub-project.
Drugs of Abuse and Remodeling of the Neuronal Cytoskeleton
Role: Co-Primary Investigator; Agency: NIH; Type: BBRC Pilot project (2G12MD007592); Total Costs: $25,000; Period: 4/1/15-3/31/16; Goal: To examine if Gβγ-mediated changes in cytoskeleton organization modulate the development of alcohol and nicotine dependence.